Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $10,019 - $11,505
-387 Reduced 4.58%
8,058 $223,000
Q4 2023

Feb 05, 2024

BUY
$26.13 - $33.94 $39,377 - $51,147
1,507 Added 21.72%
8,445 $243,000
Q3 2023

Nov 15, 2023

SELL
$32.09 - $37.51 $7,605 - $8,889
-237 Reduced 3.3%
6,938 $230,000
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $520,236 - $601,901
-14,403 Reduced 66.75%
7,175 $263,000
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $183,793 - $239,272
4,666 Added 27.59%
21,578 $880,000
Q4 2022

Feb 03, 2023

SELL
$41.75 - $54.5 $280,935 - $366,730
-6,729 Reduced 28.46%
16,912 $866,000
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $3,063 - $3,739
70 Added 0.3%
23,641 $1.04 Million
Q2 2022

Aug 16, 2022

BUY
$46.53 - $55.17 $1,675 - $1,986
36 Added 0.15%
23,571 $1.24 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $5,169 - $6,405
113 Added 0.48%
23,535 $1.22 Million
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $413 - $612
10 Added 0.04%
23,422 $1.38 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $3,532 - $4,537
-90 Reduced 0.38%
23,412 $1.01 Million
Q2 2021

Aug 09, 2021

BUY
$35.91 - $40.68 $969 - $1,098
27 Added 0.12%
23,502 $920,000
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $5,090 - $5,741
152 Added 0.65%
23,475 $850,000
Q4 2020

Feb 08, 2021

BUY
$33.47 - $42.56 $341,862 - $434,707
10,214 Added 77.92%
23,323 $858,000
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $22,733 - $26,671
716 Added 5.78%
13,109 $481,000
Q2 2020

Aug 04, 2020

BUY
$30.12 - $36.54 $2,680 - $3,252
89 Added 0.72%
12,393 $405,000
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $29,030 - $41,477
-1,074 Reduced 8.03%
12,304 $402,000
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $440,403 - $499,802
13,378 New
13,378 $524,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $167B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mine & Arao Wealth Creation & Management, Llc. Portfolio

Follow Mine & Arao Wealth Creation & Management, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mine & Arao Wealth Creation & Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mine & Arao Wealth Creation & Management, Llc. with notifications on news.